Saad Zafar Usmani
Saad Zafar Usmani
Saad Zafar Usmani, M.D., FACP is the Chief of Plasma Cell Disorder program and the Director of Clinical Research in Hematologic Malignancies at the Levine Cancer Institute/Carolinas Healthcare System. He is an internationally recognized clinical and translational researcher focused on plasma cell disorders in general, and high-risk multiple myeloma in specific. He is a specialist in Hematology, Medical Oncology and Bone Marrow Transplantation. He also holds an academic appointment as Clinical Professor of Medicine at the UNC-Chapel Hill School of Medicine. He has research numerous research funding from the NCI, IMF, MMRF and other foundations. Dr. Usmani received his medical education at Allama Iqbal Medical College Lahore, Pakistan. He completed a residency in Internal Medicine at Sinai-Grace Hospital/Wayne State University in Detroit, Michigan, and a fellowship in Hematology & Oncology at the University of Connecticut Health Center in Farmington, Connecticut.
Prior to joining Levine Cancer Institute, Dr. Usmani was an Assistant Professor of Medicine at the University of Arkansas for Medical Sciences in Little Rock, AR where he served as the Director of Developmental Therapeutics at the Myeloma Institute for Research & Therapy. He is a member of the International Myeloma Working Group, the SWOG Myeloma Committee, the American Society of Hematology, the American Society of Clinical Oncology and the American Society of Bone Marrow Transplantation. He is also serving on the BMT-CTN Myeloma Committee , the ASH Committee on Plasma Cell Neoplasia, and the NCI Myeloma Steering Committee. He is on the editorial review board of numerous medical journals, has authored/co-authored over 200 abstracts and peer-reviewed manuscripts.